Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) stock closed at 0.4273 per share at the end of the most recent trading day (a -8.03% change compared to the prior day closing price) with a volume of 947.71K shares and market capitalization of 63.61M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 171 people. Adamis Pharmaceuticals Corporation CEO is Dennis J. Carlo.

The one-year performance of Adamis Pharmaceuticals Corporation stock is -44.48%, while year-to-date (YTD) performance is -29.37%. ADMP stock has a five-year performance of -88.61%. Its 52-week range is between 0.3118 and 1.48, which gives ADMP stock a 52-week price range ratio of 9.67%

Adamis Pharmaceuticals Corporation currently has a PE ratio of -1.20, a price-to-book (PB) ratio of 2.23, a price-to-sale (PS) ratio of -36.62, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -136.73%, a ROC of -248.16% and a ROE of -314.55%. The company’s profit margin is -%, its EBITDA margin is -1 501.20%, and its revenue ttm is $-1 899 850.00 , which makes it $-0.01 revenue per share.

Of the last four earnings reports from Adamis Pharmaceuticals Corporation, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.03 for the next earnings report. Adamis Pharmaceuticals Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Adamis Pharmaceuticals Corporation is Hold (3), with a target price of $1.25, which is +194.26% compared to the current price. The earnings rating for Adamis Pharmaceuticals Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Adamis Pharmaceuticals Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Adamis Pharmaceuticals Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 23.91, ATR14 : 0.05, CCI20 : -44.57, Chaikin Money Flow : 0.01, MACD : -0.03, Money Flow Index : 36.56, ROC : 8.87, RSI : 47.64, STOCH (14,3) : 61.40, STOCH RSI : 0.79, UO : 59.32, Williams %R : -38.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Adamis Pharmaceuticals Corporation in the last 12-months were: David C. Benedicto (Sold 3 603 shares of value $2 208 ), David J. Marguglio (Sold 11 859 shares of value $7 117 ), Dennis J. Carlo (Sold 10 490 shares of value $6 287 ), Ronald B. Moss (Sold 8 199 shares of value $4 949 )